| (11beta)-11,21-Dihydroxy-17-(1-oxobutoxy)pregn-4-ene-3,20-dione |
| (1S,10S,11S,15S,17S,2R,14R)-17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-5-ox otetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl butanoate |
| (1S,2R,10S,11S,14R,15S,17S)-17-HYDROXY-14-(2-HYDROXYACETYL)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL BUTANOATE |
| [(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11-oxidanyl-17-(2-oxidanylethanoyl)-3-oxidanylidene-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate |
| [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate |
| [11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate |
| 05RMF7YPWN |
| 11-beta,17-alpha,21-Trihydroxy-4-pregnene-3,20-dione 17-alpha-butyrate |
| 11-beta,17-alpha,21-trihydroxy-4-pregnene-3,20-dione17-alpha-butyrate |
| 11|A,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate |
| 11b,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate |
| 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butyrate |
| 11beta,21-dihydroxy-17alpha-butyryloxy-4-pregnene-3,20-dione |
| 11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl butanoate |
| 135467-84-4 |
| 13609-67-1 |
| 17-O-butyrylcortisol |
| 4CA-0622 |
| 609H671 |
| A807026 |
| AB00052341_02 |
| AC-492 |
| AC1L1AHF |
| AC1L1GE2 |
| ACMC-20mvrv |
| AJ-47560 |
| AKOS015895443 |
| Alfason |
| AN-15773 |
| API0005043 |
| AX8134121 |
| BC214764 |
| BSPBio_003158 |
| Bucort |
| butanoic acid [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] ester |
| Butyric acid hydrocortisone |
| CAS-13609-67-1 |
| CCG-39923 |
| CHEBI:31674 |
| CHEMBL1434261 |
| CHEMBL1683 |
| Cortisol 17-butyrate |
| CORTISOL, 17-BUTYRATE |
| CS-4474 |
| CTK0H7965 |
| D01619 |
| DivK1c_000743 |
| DSSTox_CID_25896 |
| DSSTox_GSID_45896 |
| DSSTox_RID_81208 |
| DTXSID4045896 |
| EINECS 237-093-4 |
| Epitope ID:119710 |
| H-17-B |
| H.17B |
| HB(sub 17) |
| hb(sub17) |
| HMS1922O17 |
| HMS2093C09 |
| HMS2231B16 |
| HMS502F05 |
| HY-B0983 |
| Hycortate |
| Hydrocortisone 17-butyrate |
| Hydrocortisone 17alpha-butyrate |
| hydrocortisone butyrate |
| Hydrocortisone Butyrate (Hydrocortisone 17-Butyrate) |
| Hydrocortisone butyrate (JP17/USP) |
| Hydrocortisone butyrate [USAN:BAN:JAN] |
| Hydrocortisone butyrate [USAN:USP:BAN:JAN] |
| Hydrocortisone butyrate, United States Pharmacopeia (USP) Reference Standard |
| Hydrocortisone-17-butyrate |
| Hydrocortisone-17alpha-butyrate |
| I06-0576 |
| IDI1_000743 |
| KBio1_000743 |
| KBio2_002131 |
| KBio2_004699 |
| KBio2_007267 |
| KBio3_002658 |
| KBioGR_001042 |
| KBioSS_002131 |
| Lacoid |
| Lacoidon |
| Laticort |
| locoid (TN) |
| LS-54996 |
| LT00244772 |
| MCULE-5041290339 |
| MFCD00083364 |
| MLS000028716 |
| MLS001076086 |
| MLS002207122 |
| MolPort-003-941-574 |
| NCGC00095037-01 |
| NCGC00159427-02 |
| NCGC00178233-01 |
| NCGC00274077-01 |
| NINDS_000743 |
| NSC-758433 |
| NSC758433 |
| Opera_ID_188 |
| Pharmakon1600-01503273 |
| PL000382 |
| Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11-beta)- |
| Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11beta)- |
| SBI-0051808.P002 |
| SCHEMBL14936050 |
| SCHEMBL4695 |
| SMR000058859 |
| SPBio_001212 |
| Spectrum_001651 |
| SPECTRUM1503273 |
| Spectrum2_001106 |
| Spectrum3_001589 |
| Spectrum4_000581 |
| Spectrum5_001171 |
| ST075194 |
| Tox21_111397 |
| Tox21_111397_1 |
| UNII-05RMF7YPWN |
| VA11057 |
| W-108252 |
| ZINC34779372 |
| ZINC3977794 |
